CYP1B1 and breast carcinoma: The differences in breast cancer risk associated with the CYP1B1 Val432Leu polymorphism in different populations may be due to several reasons including differences in frequency of Val and Leu alleles in different populations, the relatively small sample size of some studies [4,11,13,25,26], as well as differences in study designs.